Cleared Traditional

K934065 - MEDTRONIC MATTRIX 3271/3272 NEUROSTIMUL...

K934065 is the FDA 510(k) clearance for MEDTRONIC MATTRIX 3271/3272 NEUROSTIMUL... by Medtronic Vascular. It is a Class 2 Neurology device (product code GZB) cleared through the Traditional 510(k) pathway after a 543-day FDA review.

K934065 · Medtronic Vascular · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1995
Decision
543d
Days
Class 2
Risk

K934065 is an FDA 510(k) clearance for the MEDTRONIC MATTRIX 3271/3272 NEUROSTIMULATION SYSTEM. Classified as Stimulator, Spinal-cord, Implanted (pain Relief) (product code GZB), Class II - Special Controls.

Submitted by Medtronic Vascular (Minneapolis, US). The FDA issued a Cleared decision on February 14, 1995 after a review of 543 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5880 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Neurology submissions.

View all Medtronic Vascular devices

Submission Details

510(k) Number K934065 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 20, 1993
Decision Date February 14, 1995
Days to Decision 543 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
395d slower than avg
Panel avg: 148d · This submission: 543d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GZB Stimulator, Spinal-cord, Implanted (pain Relief)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5880
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZB Stimulator, Spinal-cord, Implanted (pain Relief)

All 74
Devices cleared under the same product code (GZB) and FDA review panel - the closest regulatory comparables to K934065.
MODEL NOS. 7495 AND 501826 EXTENSIONS
K954886 · Medtronic Vascular · Nov 1995
MEDTRONIC MODEL 3991, 3991C, 3992, 3992C, 3993, 3993C, 3994, 3994C LEADS OR, TRANSVERSE TRIPOLAR LEADS OR, TTL
K952459 · Medtronic Vascular · Aug 1995
MODEL 3470 X-TREL RF RECEIVER
K943537 · Medtronic Vascular · Apr 1995
ALTERNATE 100% ETO STERILIZATION PROCESS AND ALTERNATE STERILIZATION FACCILITY
K950127 · Medtronic Vascular · Jan 1995
TEMP AND PERMANENT NEURO LEADS (VARIOUS MODELS)
K945103 · Medtronic Vascular · Jan 1995
NEUROLOGICAL LEADS (PACKAGING MODIFICATION)
K940416 · Medtronic Vascular · Jul 1994